Abstract
Liposome-mediated gene transfer is currently sub-optimal with respect to both the extent and duration of transgene expression. We investigated whether simple changes in DNA dosing could enhance either of these outcomes. Increasing DNA doses produced highest transgene expression at an intermediate dose with toxicity observed at higher doses, thereby likely limiting expression. Adminis- tering an equivalent DNA dose in aliquots over a 1–3 day period resulted in significantly lower gene expression and did not increase the duration of expression. Administration at different times of the day (and hence wake/sleep cycles of the animals) did not alter gene expression. We conclude that such simple changes in dosing regimes are unlikely to contribute to improvements in gene transfer efficiency.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Quinton PM . Cystic fibrosis: a disease in electrolyte transport FASEB J 1990 4: 2709–2717
Riordan JR et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA Science 1989 245: 1066–1073
Alton EWFW et al. Towards gene therapy of cystic fibrosis: a clinical progress report Gene Therapy 1998 5: 291–292
Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis Nature Med 1995 1: 39–46
Sandhu JS, Keating A, Hozumi N . Human gene therapy Crit Rev Biotech 1997 17: 307–326
Cunliffe V, Thatcher D, Craig R . Innovative approaches to gene therapy Curr Opin Biotech 1995 6: 709–713
Kitson C et al. The extra and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium Gene Therapy 1999 6: 534–546
Duncan JE, Whitsett JA, Horowitz AD . Pulmonary surfactant inhibits cationic-mediated gene delivery to respiratory epithelial cells in vitro Hum Gene Ther 1997 8: 531–538
McCray PB Jr et al. Alveolar macrophages inhibit retrovirus-mediated gene transfer to airway epithelia Hum Gene Ther 1997 8: 1087–1093
Matsui H et al. Loss of binding and entry of liposome–DNA complexes decreases transfection efficiency in differentiated airway epithelial cells J Biol Chem 1997 272: 1117–1126
Zabner J et al. Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time J Virol 1996 70: 6994–7003
Zabner J et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis J Clin Invest 1996 97: 1504–1511
McLachlan G et al. Evaluation in vitro and in vivo of cationic liposome-expression construct complexes for cystic fibrosis gene therapy Gene Therapy 1995 2: 614–622
Goddard CA et al. A second dose of a CFTR cDNA–liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea GeneTherapy 1997 4: 1231–1236
Bateman JR, Pavia D, Clarke SW . The retention of lung secretions during the night in normal subjects Clin Sci Mol Med Suppl 1978 55: 523–527
Scheule R et al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung Hum Gene Ther 1997 8: 689–707
Schwartz DA et al. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract J Clin Invest 1997 100: 68–73
Alton EWFW et al. A double-blind placebo-controlled trial of cationic lipid-mediated CFTR gene transfer to the lungs and nose of CF subjects Lancet 1999 353: 947–954
Song W, Kong HL, Traktman P, Crystal RG . Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors Hum Gene Ther 1997 8: 1207–1217
Yang Y, Li Q, Ertl HC, Wilson JM . Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses J Virol 1995 69: 2004–2015
Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung Hum Gene Ther 1996 7: 1701–1717
Acknowledgements
The study was supported by the Cystic Fibrosis Research Trust and by a Wellcome Trust Senior Clinical Fellowship (EWFWA).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hillery, E., Cheng, S., Geddes, D. et al. Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epithelium. Gene Ther 6, 1313–1316 (1999). https://doi.org/10.1038/sj.gt.3300953
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3300953
Keywords
This article is cited by
-
Use of ultrasound to enhance nonviral lung gene transfer in vivo
Gene Therapy (2007)
-
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo
Gene Therapy (2006)
-
Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo
Gene Therapy (2003)
-
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter
Gene Therapy (2001)
-
Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema
Gene Therapy (2000)